Clinical management of patients with a history of urticaria/angioedema induced by multiple NSAIDs: An expert panel review

International Archives of Allergy and Immunology

Volumn 160, Issue 2, 2013, Pages 126-133

  Asero, Riccardo ^a   Bavbek, Sevim ^f   Blanca, Miguel ^g   Blanca Lopez, Natalia ^h   Cortellini, Gabriele ^b   Nizankowska Mogilnicka, Ewa ⁱ   Quaratino, Donato ^c   Romano, Antonino ^d,e   Sanchez Borges, Mario ^j   Torres Jaen, Maria Josè ^g  

^a Ospedale 21   (Italy)

^b UO Medicina Interna e Reumatologia   (Italy)

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^d Allergy Unit   (Italy)

^e OASI RESEARCH INSTITUTE IRCCS   (Italy)

^f ANKARA UNIVERSITY   (Turkey)

^g HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^h HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

ⁱ JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^j Centro Medico Docente La Trinidad   (Venezuela)

more..

Author keywords

COX 1; COX 2; Cross reactivity; Nonsteroidal anti inflammatory drug hypersensitivity; NSAID; Oral challenge tests; Urticaria

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; DICLOFENAC; DIFLUNISAL; ETODOLAC; ETORICOXIB; FENOPROFEN; FEPRAZONE; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; MECLOFENAMIC ACID; MEFENAMIC ACID; MELOXICAM; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; NORAMIDOPYRINE; OXYPHENBUTAZONE; PHENYLBUTAZONE; PIROXICAM; PROPIONIC ACID DERIVATIVE; ROFECOXIB; SALSALATE; SULINDAC; TOLMETIN; ANTIHISTAMINIC AGENT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR;

ANGIONEUROTIC EDEMA; DRUG CLASSIFICATION; DRUG HYPERSENSITIVITY; DRUG TOLERANCE; ENZYME INHIBITION; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; URTICARIA; ANAMNESIS; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DRUG CROSS REACTIVITY; DRUG INDUCED DISEASE; DRUG TOLERABILITY; MEDICAL HISTORY; PATIENT CARE; PRACTICE GUIDELINE; PROVOCATION TEST; RELIABILITY;

ANGIOEDEMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG HYPERSENSITIVITY; HUMANS; URTICARIA;

EID: 84866679970     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000342424     Document Type: Review

References (51)

1. Settipane RA, Constantine HP, Settipane GA: Aspirin intolerance and recurrent urticaria in normal adults and children. Allergy 1980; 35: 149-154.
2. Mathison DA, Lumry WS, Stevenson DD, Curd JG: Aspirin in chronic urticaria and/or angioedema: Studies of sensitivity and desensitisation (abstract). J Allergy Clin Immunol 1982; 69(suppl):135.
3. Stevenson DD, Simon RA: Sensitivity to aspirin and nonsteroidal anti-inflammatory drugs; in Middleton E, Reed CE, Ellis EF, et al (eds): Allergy: Principles and Practice, ed 4. St. Louis, Mosby, 1993, pp 1747-1765.
4. Pacor ML, Di Lorenzo G, Biasi D, Barbagallo M, Corrocher R: Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or nonsteroidal antiinflammatory drugs. Clin Exp Allergy 2002; 32: 397-400.
5. Zembowicz A, Mastalerz L, Setkowicz M, Radziszewski W, Szczeklik A: Safety of cycloxygenase 2 inhibitors and increased leukotriene synthesis in chronic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs. Arch Dermatol 2003; 139: 1577-1582.
6. Asero R: Etoricoxib challenge in patients with chronic urticaria with NSAID intolerance. Clin Exp Dermatol 2007; 32: 661-663.
7. Bae JS, Kin SH, Ye YM, Yoon HJ, et al: Significant association of Fc RI promoter polymorphisms with aspirin-intolerant chronic urticaria. J Allergy Clin Immunol 2007; 119: 449-456.
8. Kim SH, Ye YM, Palikhe NS, Kim JE, Park HS: Genetic and ethnic risk factors associated with drug hypersensitivity. Curr Opin Allergy Clin Immunol 2010; 10: 280-290.
9. Sanchez-Borges M, Acevedo N, Vergara Jimenez S, Zabner-Oziel P, Monzon A, Caraballo L: The A-444C polymorphism in the leukotriene C4 synthase gene is associated with aspirin-induced urticaria. J Investig Allergol Clin Immunol 2009; 19: 375-382.
10. Szczeklik A: Adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. Ann Allergy 1987; 57: 113-118.
11. Papa G, Romano A, Del Bono A, et al: Floctafenine: A valid alternative in patients with adverse reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 1997; 78: 74-78.
12. Pastorello E, Zara C, Riario-Sforza GG, et al: Atopy and intolerance of antimicrobial drugs increase the risk of reactions to acetaminophen and nimesulide in patients allergic to nonsteroidal anti-inflammatory drugs. Allergy 1998; 53: 880-884.
13. Quaratino D, Romano A, Papa G, et al: Longterm tolerability of nimesulide and acetaminophen in nonsteroidal anti-inflammatory drug-intolerant patients. Ann Allergy Asthma Immunol 1997; 79: 47-50.
14. Quiralte J, Blanco C, Castillo R, et al: Intolerance to nonsteroidal anti-inflammatory drugs: Results of controlled drug challenges in 98 patients. J Allergy Clin Immunol 1996; 98: 678-685.
15. Sanchez-Borges M, Capriles-Hulett A: Atopy is a risk factor for nonsteroidal anti-inflammatory drug sensitivity. Ann Allergy Asthma Immunol 2000; 84: 101-106.
16. Asero R: Detection of aspirin reactivity in patients with pyrazolones-induced skin disorders. Allergy 1998; 53: 214-215.
17. Asero R: Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders. Ann Allergy Asthma Immunol 1999; 82: 554-558.
18. Asero R: Multiple sensitivity to NSAID. Allergy 2000; 55: 893-894.
19. Doña I, Blanca-Lopez N, Cornejo-Garcia JA, Torres MJ, et al: Characteristics of subjects experiencing hypersensitivity to non-Steroidal anti-inflammatory drugs: Pattern of response. Clin Exp Allergy 2011; 41: 86-95.
20. Carmona MJ, Blanca M, Garcia A, et al: Intolerance to piroxicam in patients with adverse reactions to nonsteroidal antiinflammatory drugs. J Allergy Clin Immunol 1992; 90: 873-879.
21. Andri L, Senna G, Betteli C, et al: Tolerability of nimesulide in aspirin-Sensitive patients. Ann Allergy 1994; 72: 29-32.
22. Ispano M, Fontana A, Scibilia J, Ortolani C: Oral challenge with alternative nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol in patients intolerant to these agents. Drugs 1993; 46(suppl):253-256.
23. Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F, Perez CR: Tolerability to new COX-2 inhibitors in NSAID-Sensitive patients with cutaneous reactions. Ann Allergy Asthma Immunol 2001; 87: 201-204.
24. Asero R: Tolerability of rofecoxib. Allergy 2001; 56: 916-917.
25. Nettis E, Di Paola R, Ferrannini A, Tursi A: Tolerability of rofecoxib in patients with cutaneous adverse reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 2002; 88: 331-334.
26. Nettis E, Di Paola R, Ferrannini A, et al: Meloxicam in hypersensitivity to NSAIDs. Allergy 2001; 56: 803-804.
27. Asero R: Chronic urticaria with multiple NSAID intolerance: Is tramadol always a safe alternative analgesic? J Investig Allergol Clin Immunol 2003; 13: 55-58.
28. Goksel O, Aydin O, Misirligil Z, Demirel YS, Bavbek S: Safety of meloxicam in patients with aspirin/non-Steroidal anti-inflammatory drug-induced urticaria and angioedema. J Dermatol 2010; 37: 973-979.
29. Quaratino D, Romano A, Di Fonso M, Papa G, Perrone MR, et al: Tolerability of meloxicam in patients with histories of adverse reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 2000; 84: 613-617.
30. Asero R: Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria. Ann Allergy Asthma Immunol 2000; 85: 156-157.
31. Perez C, Sanchez-Borges M, Capriles E: Pretreatment with montelukast blocks NSAIDinduced urticaria and angioedema. J Allergy Clin Immunol 2001; 108: 1060-1061.
32. Mastalerz L, Setkowicz M, Sanak M, Szczeklik A: Hypersensitivity to aspirin: Common eicosanoids alterations in urticaria and asthma. J Allergy Clin Immunol 2004; 113: 771-775.
33. Asero R: Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria. J Allergy Clin Immunol 2003; 111: 1095-1098.
34. Sanchez-Borges M, Acevedo N, Caraballo L, Capriles-Hulett A, Caballero-Fonseca F: Increased total and mite-Specific immunoglobulin E in patients with aspirin-induced urticaria and angioedema. J Investig Allergol Clin Immunol 2010; 20: 139-145.
35. Stevenson DD, Sanchez-Borges M, Szczeklik A: Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclo-oxygenase enzymes (editorial). Ann Allergy Asthma Immunol 2001; 87: 1-4.
36. Kowalski ML, Makowska JS, Blanca M, Bavbek S, Bochenek G, Bousquet J, et al: Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: Review of the EAACI/ENDA and GA2LEN/HANNA. Allergy 2011; 66: 818-829.
37. Viola M, Rumi G, Valluzzi RL, Gaeta F, Caruso C, Romano A: Assessing potential determinants of positive provocation tests in subjects with NSAID hypersensitivity. Clin Exp Allergy 2011; 41: 96-103.
38. Blanca-Lopez N, Doña I, Torres MJ, Campo P, Rondón C, et al: Value of the clinical history in the diagnosis of NSAID hypersensitivity reactions induced by cross-intolerance. Clin Exp Allergy, in press
39. Asero R: Oral aspirin challenges in patients with a history of intolerance to single nonsteroidal anti-inflammatory drugs. Clin Exp Allergy 2005; 35: 713-716.
40. Malskat WSJ, van der Tas C, Knulst AC, Bruijnzeel-Koomen CA, Rockmann H: Aspirin tolerance in patients with NSAID hypersensitivity. Allergy 2010; 65: 1197-1198.
41. Asero R: Use of ketoprofen oral challenges to detect cross-reactors among patients with a history of aspirin-induced urticaria. Ann Allergy Asthma Immunol 2006; 97: 187-189.
42. Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR: Nonsteroid drug selectivities for cyclo-oxygenase 1 rather than cyclo-oxygenase 2 are associated with human gastrointestinal toxicity: A full in vitro analysis. Proc Natl Acad Sci USA 1999; 96: 7563-7568.
43. Doña I, Blanca-Lopez N, Jagemann LR, Torres MJ, Rondón C, et al: Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs. Allergy 2011; 66: 1428-1433.
44. Pleskow WW, Stevenson DD, Mathison DA, Simon RA, Schatz M, Zeiger RS: Aspirin desensitization in aspirin-Sensitive asthmatic patients: Clinical manifestations and characterization of the refractory period. J Allergy Clin Immunol 1982; 69: 11-19.
45. Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F: NSAID-induced urticaria and angioedema: A reappraisal of its clinical management. Am J Clin Dermatol 2002; 3: 599-607.
46. Asero R: Cetirizine premedication prevents acute urticaria induced by weak COX-1 inhibitors in multiple NSAID reactors. Eur Ann Allergy Clin Immunol 2010; 42: 174-177.
47. Celik G, Erkekol FO, Bavbek S, Dursun B, Misirligil Z: Long-Term use and tolerability of cyclooxygenase-2 inhibitors in patients with analgesic intolerance. Ann Allergy Asthma Immunol 2005; 95: 33-37.
48. Pagani M, Bonadonna P, Dama A, Senna GE, Vescovi PP, Antico A: Long-Term tolerability of etoricoxib in different types of NSAIDintolerant subjects. Eur Ann Allergy Clin Immunol 2010; 42: 216-220.
49. Nettis E, Colanardi MC, Ferrannini A, Vaccca A, Tursi A: Short-Term tolerability of etoricoxib in patients with cutaneous hypersensitivity reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 2005; 95: 438-442.
50. Muratore L, Ventura M, Calogiuri G, Calcagnile F, Quarta E, Muratore M, Ferrannini A: Tolerance to etoricoxib in 37 patients with urticaria and angioedema induced by nonsteroidal anti-inflammmatory drugs. Ann Allergy Asthma Immunol 2007; 98: 168-171.
51. Viola M, Quaratino D, Gaeta F, Caruso C, Valluzzi R, Romano A: Etoricoxib tolerability in patients with hypersensitivity to nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol 2007; 143: 103-108.